The trkC gene encodes the high-anity receptor for neurotrophin 3 and plays an important role in the regulation of the survival and dierentiation of the mammalian nervous system and in heart development. Chromosomal rearrangements of trkC have been recently reported in congenital ®brosarcoma and it has been proposed that abnormal activation of this gene might be involved in tumor development. To facilitate the search for new mutations and rearrangements in the human trkC locus we have partially characterized its genomic organization by restriction mapping and have obtained the complete intron-exon structure. Our results show that human trkC consists of 20 exons, including two that encode the inserts present in the extracellular and tyrosine kinase domains, and another two that encode the carboxyl-terminal tail of the truncated TRKC isoform. Analysis of the 5'¯anking region revealed the absence of TATA box, a very high content in C/G compatible with a CpG island and the presence of putative binding sites for the AP1, AP2, GC, ATF, BRN2, AML1 and Nkx2.5 transcription factors.
sequence
The trkC gene (also known as NTRK3) is located on chromosome 15q25 (McGregor et al., 1994) and encodes the high-anity receptor for neurotrophin 3 (NT-3), a member of the highly homologous family of neurotrophic factors (Lamballe et al., 1991) . TRKC and NT-3 contribute to the regulation of proliferation, survival and dierentiation of several cell populations in the mammalian nervous system, especially those of sensory neurons involved in propioception (Ernfors et al., 1994; Klein et al., 1994) . It has recently been shown that NT-3 and TRKC also play an important role in the development of the mammalian heart (Donovan et al., 1996; Tessarollo et al., 1997) .
The product of the trkC gene is a 145 KDa glycoprotein (Lamballe et al., 1991) that exhibits the same structural features as other TRK receptors; namely, a signal sequence, two cysteine-rich domains anking a leucine-rich domain, two Ig-like domains of the C2 type, a transmembrane domain, and a tyrosine kinase domain showing high similarity to other known tyrosine kinases (Schneider and Schweiger, 1991; Barbacid, 1994) . Like other members of the TRK receptor family, TRKC is encoded by a single gene but has more than one isoform. Unlike what is found in the rat, where inserts of 14, 25 and 39 aminoacids have been described (Lamballe et al., 1993; Tsoulfas et al., 1993; Valenzuela et al., 1993) , the presence or absence of a unique insert of 14 aminoacids in the tyrosine kinase domain of the human trkC generates two isoforms (McGregor et al., 1994; Shelton et al., 1995) . Moreover, human trkC transcript undergoes alternative splicing that generates two isoforms diering in the presence or absence of a 9 amino acid insert in the extracellular domain (Shelton et al., 1995) . This 9-amino acid insert is located in the region between the second Ig-like domain and the transmembrane domain, in a position analogous to that of the extracellular insert described for human trkA (Barker et al., 1993) . It has also been described a non-catalytic form of the human trkC that does not contain the consensus tyrosine kinase domain but rather an alternative intracellular domain of 83 residues that has also been reported in other species (Tsoulfas et al., 1993; Valenzuela et al., 1993; Shelton et al., 1995) .
Oncogenic activation through DNA rearrangements is a frequent event involving receptor tyrosine kinase genes. For instance, the trkA gene, that was originally discovered as part of a transforming sequence in a colon carcinoma (MartõÂ n-Zanca et al., 1986 , 1989 and the ret gene are frequently activated as oncogenes in human papillary thyroid carcinoma (Pierotti et al., 1996) . A novel t(12;15)(p13;q25) chromosomal rearrangement that fuses the trkC gene with the tel gene has recently been reported in congenital ®brosarcoma (Knezevich et al., 1998) . The tel-trkC chimaeric transcripts encode the helix ± loop ± helix (HLH) dimerization domain of TEL fused to the tyrosine kinase domain of TRKC. As a consequence, the TRKC binding domain is replaced by the HLH domain of TEL. The fusion protein may produce a HLHmediated dimerization of the chimaeric protein and a ligand-independent activation of the TRKC kinase. In addition, since TEL is widely expressed in mammalian tissues the translocation might induce the ectopic expression the TRKC tyrosine kinase.
Tyrosine kinase receptor genes can also be the target for point mutations associated with cancer or other human diseases. In this regard, mutations of the trkA gene have been reported in congenital insensitivity to pain with anhidrosis (CIPA) (Indo et al., 1996) , and mutations of the ret proto-oncogene have been identi®ed in inherited diseases such as Hirschsprung disease and the tumor syndromes MEN2A, MEN2B and FMTC (Pasini et al., 1996) . It is also expected that the trkC receptor gene could be aected by point mutations either in tumors or in human disorders arising from cells in which this gene is expressed and where it plays a physiological role.
Moreover, the level of expression of trkC is a good prognostic indicator for patients with medulloblastoma, the most common malignant brain tumor in childhood (Segal et al., 1994) , and is also linked to favorable outcome in neuroblastomas (Ryden et al., 1996; Yamashiro et al., 1996) . Hence, characterization of the trkC promoter would be essential to elucidate the mechanisms responsible for the expression of trkC.
As a tool that should help in the search for mutations and novel rearrangements involving the trkC locus in human diseases, we undertook the characterization of its genomic organization. To obtain the appropriate probes to isolate the human trkC locus, we ®rst screened a human brain stem cDNA library (Stratagene) and a human whole brain cDNA library (Clontech) using a chicken full-length trkC cDNA probe (kindly provided by E Becker). Several cDNA clones were obtained. Two of them, pNIJ-3 and hb-1, contained the entire coding region of human trkC and extended into the 5' untranslated region (UTR). Sequencing of the hb-1 cDNA clone revealed a 115 bp long sequence within the 5' UTR that is not present in the cDNA sequence previously published by McGregor et al. (1994) . The 5' end of clone pNIJ-3 also contains the last 80 bp of this sequence ( Figure 2 ). The screening of the two cDNA libraries did not allow the isolation of any cDNA encoding a truncated form of trkC. Probes from the Cloning of human trkC N Ichaso et al region encoding the truncated isoform were obtained by PCR with a pair of speci®c primers derived from the cDNA sequence of this region using the above mentioned libraries as DNA template. Screening of a human genomic library constructed in the l2001 phage vector (kindly provided by TH Rabbitts) with clone pNIJ-3, the PCR product that contains the truncated region, and oligonucleotide probes designed from the extracellular and tyrosine kinase domain alternative inserts allowed the isolation of 20 dierent genomic clones containing the complete coding sequence (Figure 1) . Our results indicate that the minimum size of the trkC locus is 85 kb. After restriction analysis of the phage's inserts, the fragments II KS plasmid vectors (Stratagene) and subjected to sequencing using either T3 and T7 primers or oligonucleotides derived from the known sequence of the trkC cDNA. This allowed us to sequence the exons and to de®ne the exon-intron boundaries and the¯anking intronic sequences.
Our analysis revealed that the human trkC gene comprises 20 exons and 19 introns. Table 1 shows the 20 nucleotides¯anking each exon-intron junction. The size of the exons ranges from 24 ± 297 bp, with the exception of exon 1, which contains the 5' UTR and whose minimum size is 877 bp, and exons 14b and 18, which contain the 3' UTRs and whose lengths have not been determined (Table 1) . Although all the intronic donor and acceptor splice sites conform to the consensus GT-AG mRNA splice sites (Table 1) , a high number of the exon sequences involved in the processing of mRNA display infrequent nucleotides. This is specially evident in the last nucleotide of exons 1 ± 4, 7, 9 and 12 which show a T instead of a G, similar to what has been found in the TrkA gene . The presence of a T as the last nucleotide of an exon has been only found in an 8% of all primate introns (Shapiro and Senapathy, 1987) and is very frequent in the U12-type of GT-AG introns (Sharp and Burge, 1997) . The oncogenic rearrangements described in congenital ®brosarcoma are located within the intron previous to exon 13 (Knezevich et al., 1998) . Exons 9 and 16, which encode respectively the 24 bp and 42 bp extracellular and kinase inserts, are also included in Table 1 . It is interesting that the intracellular domain of the truncated isoform reported by Shelton et al. (1995) is encoded by two exons: 13b and 14b. However, we were unable to locate these exons within the genomic map (Figure 1) .
The translation initiation codon (ATG) is located in exon 1 and the stop codons giving rise to the truncated and full-length isoforms are located in exons 14b and 18, respectively. Exon 1 contains the 5' UTR and encodes the signal peptide, the cysteine cluster 1, and the beginning of the leucine-rich motif; exons 1 to 4 encode the leucine-rich motif; the cysteine cluster 2 is encoded by exons 4 and 5; the Ig-like domain 1 by exons 6 and 7; the Ig-like domain 2 by exon 8; the transmembrane domain by exons 10 and 11; the juxtamembrane region by exons 11 ± 13; the tyrosine kinase domain by exons 13 ± 18. Exon 9 and exon 16 encode the alternative inserts present in the extracellular and tyrosine kinase domains, and exons 13b and 14b the terminal domain of the truncated isoform (Shelton et al., 1995) . The carboxyl terminal tail and 3' UTRs of the truncated and full-length isoforms are encoded by exons 14b and 18, respectively.
Analysis of the 5' genomic region shows that the sequence between nucleotides 7130 to 716 corresponds to the 115 bp sequence present within the 5' UTR of the cDNA clone hb-1. Nucleotides 793 to 716 correspond to the 5' end of the pNIJ-3 cDNA clone. This sequence is not present in the trkC cDNA sequence previously reported by McGregor et al. (1994) (Figure 2 ). These 115 base pairs may correspond to an unprocessed intron localized 16 bp upstream to the ATG. If this were the case, the putative intron would contain a consensus 3' splice site. However, this putative intron would lack thè invariant' GT dinucleotide located at the ®rst two positions of the intronic 5' splice site, which is replaced Figure 3 Analysis of the CG dinucleotide content of trkC exon 1 and¯anking regions. Graphic representation of the percentage of CG dinucleotides (gray) and GC dinucleotides (black). CG and GC localizations and sites for the enzymes NotI, HpaII, NarI, SmaI, NaeI and SacII are shown. Sites for EcoRI, SacI, ApaI, XbaI and PstI are also shown. The region analysed in the study is represented at the bottom of the ®gure, where exon 1 is shown as an open bar by a GC dinucleotide. This substitution is the only one which still allows accurate cleavage of the 5' site, albeit more slowly than the usual GT sequence (Aebi et al., 1987) and has only been reported as a splice variant in 26 introns (Jackson, 1991) . Moreover, none of the adenines present in this putative intron matches the consensus branch site (Sharp and Burge, 1997) . These considerations, together with the fact that this sequence is present in the two cDNA clones which extend to the 5' UTR that were isolated from two dierent libraries, led us to consider that this sequence may be part of exon 1 of the trkC gene (Figures 1 and 2) .
The remaining exonic sequences in the genomic clones were in agreement with our cDNA clones and with the cDNA sequence previously reported by McGregor et al. (1994) but showed certain individual dierences with the cDNA sequence reported by Shelton et al. (1995) .
Two putative polyadenylation sites (AATAAA and ATTAAA) were found in the 3' UTR contained in exon 14b, whereas no polyadenylation signal was found either in the 3' UTR of exon 18 or in the 200 bp 3'¯anking sequence.
A stretch of 2900 bp encompassing exon 1 and anking regions was sequenced. This region has a very high CG content consistent with a CpG island ( Figure  3 ). The genomic region of 1085 bp upstream from the 5' end of the hb-1 cDNA clone was analysed ( Figure  2 ). In addition to the high CG content, the sequence analysis revealed the absence of TATA box and the presence of multiple putative recognition sites for transcription factors, including Sp1, AP2, GC and ATF, which have also been reported in the proximal regulatory region of the trkA gene (Chang et al., 1998; Greco et al., 1996) . Besides AP2, other transcription factors known to be expressed in brain, such as BRN2, or both in heart and brain, such as AML1 and Nkx2.5, also have recognition sites in this region (Figure 2 ) (Heinemeyer et al, 1998; Quandt et al., 1995) . Nevertheless, the role of such elements in the regulation of trkC remains to be determined.
We report here the characterization of the trkC locus, in particular the exon-intron organization of the human trkC gene as well as the sequence of the 5'¯anking region of this gene. Our results provide a useful tool for screening trkC mutations in hereditary human disorders, especially in those arising from cells where trkC plays a physiological role, as well as for characterizing novel rearrangements or mutations in the trkC gene that might be involved in tumor development. EMBL accession numbers HSA224521-37.
